MBX Biosciences (MBX) News Today $14.50 -0.41 (-2.75%) Closing price 10/13/2025 04:00 PM EasternExtended Trading$14.79 +0.29 (+1.99%) As of 10/13/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period 8Dell, 89bio, MBX Biosciences and More Stocks See Action From Activist InvestorsOctober 10, 2025 | msn.comMBX Biosciences (NASDAQ:MBX) Earns "Sell (D-)" Rating from Weiss RatingsOctober 10, 2025 | marketbeat.comInsiders Snap Up $54M in Biotech and Offshore Driller StocksOctober 7, 2025 | 247wallst.comHedge Fund and Insider Trading News: George Soros, David Tepper, Warren Buffett, Davidson Kempner, Bridgewater Associates, Jain Global, MBX Biosciences Inc (MBX), United ...October 2, 2025 | insidermonkey.comPlatinum Investment Management Ltd. Lowers Stock Holdings in MBX Biosciences, Inc. $MBXOctober 2, 2025 | marketbeat.comMBX Biosciences, Inc. (NYSE:MBX) Given Consensus Rating of "Buy" by BrokeragesOctober 2, 2025 | marketbeat.comMBX Biosciences director buys $12.0M in common stockOctober 1, 2025 | msn.comPatrick Heron Buys 666,666 Shares of MBX Biosciences (NYSE:MBX) StockOctober 1, 2025 | insidertrades.comMassive Stock Purchase by MBX Biosciences Director!September 30, 2025 | tipranks.comMBX Biosciences (NYSE:MBX) Director Patrick Heron Purchases 666,666 SharesSeptember 30, 2025 | marketbeat.comMBX Biosciences (MBX) Price Target Increased by 48.48% to 57.12September 30, 2025 | msn.comGoldman Sachs Group Inc. Has $112,000 Stock Holdings in MBX Biosciences, Inc. $MBXSeptember 30, 2025 | marketbeat.comMBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic ForumSeptember 29, 2025 | globenewswire.comMBX Biosciences, Inc.: MBX Biosciences Announces Proposed Public OfferingSeptember 25, 2025 | finanznachrichten.deMBX Biosciences stock falls after pricing upsized public offeringSeptember 25, 2025 | za.investing.comMBX Biosciences Shares Drop Following Upsized Public Offering PricingSeptember 25, 2025 | msn.comMBX Biosciences (NYSE:MBX) Shares Gap Down - Should You Sell?September 25, 2025 | marketbeat.comMBX Biosciences (NASDAQ:MBX) Shares Gap Down - Time to Sell?September 25, 2025 | marketbeat.comMBX Biosciences price target raised to $56 from $38 at MizuhoSeptember 25, 2025 | msn.comMBX Biosciences 11.1M share Secondary priced at $18.00September 25, 2025 | msn.comMBX Biosciences stock down on pricing upsized public offering at $18.00 per shareSeptember 25, 2025 | msn.comMBX Biosciences, Inc. - Special CallSeptember 24, 2025 | seekingalpha.comMBX Biosciences, Inc. (MBX) Discusses On Topline Results From Avail Phase 2 Trial TranscriptSeptember 24, 2025 | seekingalpha.comMBX Biosciences Announces Pricing of Upsized Public OfferingSeptember 24, 2025 | globenewswire.comMBX Biosciences, Inc. (MBX) Biosciences, Inc. - Special Call - SlideshowSeptember 24, 2025 | seekingalpha.comMizuho Increases MBX Biosciences (NYSE:MBX) Price Target to $56.00September 24, 2025 | marketbeat.comMBX Biosciences (MBX) Is Up 84.0% After Positive Phase 2 Results for Canvuparatide - Has The Bull Case Changed?September 23, 2025 | finance.yahoo.comMBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading Volume - Still a Buy?September 23, 2025 | marketbeat.comMBX Biosciences (NYSE:MBX) Sees Unusually-High Trading Volume - Here's WhySeptember 23, 2025 | marketbeat.comMBX Biosciences Shares Climb on Planned Release of Trial DataSeptember 22, 2025 | marketwatch.comMBX Biosciences stock soars after hypoparathyroidism drug hits trial goalSeptember 22, 2025 | za.investing.comMBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label ...September 22, 2025 | markets.businessinsider.comMBX Biosciences Stock Doubles On Promising New Thyroid Disease TreatmentSeptember 22, 2025 | msn.comMBX Biosciences Shares Halt in Premarket Trading as Hypoparathyroidism Drug Shows Positive Phase 2 ResultsSeptember 22, 2025 | marketwatch.comMBX Biosciences' Experimental Drug Shows Promise In Hypoparathyroidism StudySeptember 22, 2025 | finance.yahoo.comMBX Biosciences Looks A Buy As Hypoparathyroidism Data Wows MarketSeptember 22, 2025 | seekingalpha.comMBX Biosciences Announces Proposed Public OfferingSeptember 22, 2025 | globenewswire.comMBX Biosciences (NYSE:MBX) Shares Gap Up - What's Next?September 22, 2025 | marketbeat.comMBX Biosciences (NASDAQ:MBX) Shares Gap Up - Here's What HappenedSeptember 22, 2025 | marketbeat.comMBX Biosciences Reports Positive Phase 2 Trial Results for Once-Weekly Canvuparatide in Chronic HypoparathyroidismSeptember 22, 2025 | quiverquant.comQMBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label ExtensionSeptember 22, 2025 | globenewswire.comMBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22September 19, 2025 | globenewswire.comWoodline Partners LP Has $6.48 Million Position in MBX Biosciences, Inc. $MBXSeptember 15, 2025 | marketbeat.comMBX Biosciences (NASDAQ:MBX) Upgraded at Wall Street ZenSeptember 15, 2025 | marketbeat.com133,113 Shares in MBX Biosciences, Inc. $MBX Purchased by Exome Asset Management LLCSeptember 11, 2025 | marketbeat.comMBX Biosciences, Inc. $MBX Shares Acquired by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comMBX Biosciences (NASDAQ:MBX) Stock Rating Lowered by Wall Street ZenSeptember 8, 2025 | marketbeat.comWalleye Capital LLC Purchases New Position in MBX Biosciences, Inc. $MBXSeptember 7, 2025 | marketbeat.comJump Financial LLC Purchases Shares of 28,996 MBX Biosciences, Inc. $MBXSeptember 7, 2025 | marketbeat.comMBX Biosciences, Inc.: MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of ObesitySeptember 6, 2025 | finanznachrichten.de Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MBX Media Mentions By Week MBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MBX News Sentiment▼0.581.42▲Average Manufacturing News Sentiment MBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MBX Articles This Week▼53▲MBX Articles Average Week Get the Latest News and Ratings for MBX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for MBX Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies DYN News Today ANIP News Today VERA News Today TLRY News Today TWST News Today COGT News Today GPCR News Today BHVN News Today STOK News Today ABCL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MBX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
